What was also interesting, is that Joel mentioned whoever is first to market via the FDA has 7 years of exclusivity, which is massive. He noted that they have some complex metric/system that they use that indicates that they are currently are Infront of any competitors to get the FDA approval. He also mentioned for OSA that they don't even needed to generate the same efficacy data as the phase 2, the biggest priority from the FDA perspective is safety, which is why it's 52 weeks
- Forums
- ASX - By Stock
- IHL
- Brisbane Meeting - Redomicile to USA
Brisbane Meeting - Redomicile to USA, page-60
-
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online